Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
about
68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of αvß3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.Cutaneous Metastasis of Neuroendocrine Carcinoma with Unknown Primary Site: Case Report and Review of the Literature.Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements.The Added Diagnostic Value of 18F-Fluorodihydroxyphenylalanine PET/CT in the Preoperative Work-Up of Small Bowel Neuroendocrine Tumors.Small bowel neuroendocrine tumors: A critical analysis of diagnostic work-up and operative approach.Carbidopa-assisted 18F-fluorodihydroxyphenylalanine PET/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors.UEG Week 2015 Poster Presentations
P2860
Q36228314-095A28D1-F989-407D-BB4F-F3A1583CFAD6Q38630163-546A41EE-5F00-40B7-A717-EFF1FB897D59Q38910448-86E68E68-0536-4BF8-ACF2-F42F9587F157Q47319849-EA723BC0-6602-4F49-8428-57F8087D7FA7Q51578965-085A3308-770C-4916-9764-CB90C25F5FA5Q52965503-C3049B1C-3E01-4D1C-9076-A060755DBBAAQ56934656-D4BE8C63-AA30-4914-9884-CCE1A60ED836
P2860
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
@en
type
label
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
@en
prefLabel
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
@en
P2093
P2860
P1476
Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how?
@en
P2093
Alexander Kroiss
David Taïeb
Philippe Ruszniewski
Prasanna Santhanam
Rakesh Kumar
Sangeeta Chandramahanti
P2860
P2888
P304
P356
10.1007/S00259-015-3027-4
P577
2015-03-13T00:00:00Z